Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) Enterprise Value (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Enterprise Value for 16 consecutive years, with -$85.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Enterprise Value rose 0.73% year-over-year to -$85.1 million, compared with a TTM value of -$85.1 million through Dec 2025, up 0.73%, and an annual FY2025 reading of -$85.1 million, up 0.73% over the prior year.
  • Enterprise Value was -$85.1 million for Q4 2025 at Orthofix Medical, down from -$65.9 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$28.9 million in Q2 2024 and bottomed at -$94.6 million in Q1 2021.
  • Average Enterprise Value over 5 years is -$59.7 million, with a median of -$60.0 million recorded in 2022.
  • The sharpest move saw Enterprise Value skyrocketed 53.75% in 2021, then tumbled 137.96% in 2025.
  • Year by year, Enterprise Value stood at -$87.8 million in 2021, then skyrocketed by 42.29% to -$50.7 million in 2022, then rose by 25.53% to -$37.8 million in 2023, then crashed by 127.08% to -$85.7 million in 2024, then rose by 0.73% to -$85.1 million in 2025.
  • Business Quant data shows Enterprise Value for OFIX at -$85.1 million in Q4 2025, -$65.9 million in Q3 2025, and -$68.7 million in Q2 2025.